SAKAR HEALTHCARE
Back to Balance Sheet
|
SAKAR HEALTHCARE Last 5 Year Total Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹415 Cr | ₹389 Cr | ₹336 Cr | ₹268 Cr | ₹178 Cr |
What is the latest Total Liabilities ratio of SAKAR HEALTHCARE ?
| Year | Total Liabilities |
|---|---|
| Mar2025 | ₹415 Cr |
| Mar2024 | ₹389 Cr |
| Mar2023 | ₹336 Cr |
| Mar2022 | ₹268 Cr |
| Mar2021 | ₹178 Cr |
How is Total Liabilities of SAKAR HEALTHCARE Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹415 Cr | 6.84 | |
| Mar2024 | ₹389 Cr | 15.56 | |
| Mar2023 | ₹336 Cr | 25.61 | |
| Mar2022 | ₹268 Cr | 50.61 | |
| Mar2021 | ₹178 Cr | - | |
Compare Total Liabilities of peers of SAKAR HEALTHCARE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SAKAR HEALTHCARE | ₹2,007.9 Cr | 13% | 9.8% | 150.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹465,507.0 Cr | 2.8% | 7.4% | 14.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹190,744.0 Cr | 6.4% | 8.3% | 0.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹168,250.0 Cr | 2.1% | 8.7% | 47.7% | Stock Analytics | |
| CIPLA | ₹116,213.0 Cr | 0.5% | 3.6% | -5.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,980.0 Cr | -7.6% | -2.2% | -5.8% | Stock Analytics | |
SAKAR HEALTHCARE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SAKAR HEALTHCARE | 13% |
9.8% |
150.7% |
| SENSEX | -1.4% |
4.4% |
-7.6% |
You may also like the below Video Courses